Dual facets of hyponatraemia and arginine vasopressin in patients with ACTH deficiency.
OBJECTIVE
Hyponatraemia is often observed in patients with ACTH deficiency who are thought not to suffer from volume depletion. Their high plasma AVP levels relative to plasma osmolality are presumed to be maintained by non-osmotic mechanisms. We attempted to assess volume status from changes in selected clinical measurements related to body fluid balance in the course of i.v. fluid supplementation and following glucocorticoid (GC) replacement in ACTH-deficient patients, and to interpret plasma AVP levels in the context of the estimated volume status.


METHODS
This report consists of three parts. First, an ACTH-deficient patient with hyponatraemia and volume depletion who was followed through volume replacement to recovery after GC replacement is described (case report). Secondly, medical records of five ACTH-deficient patients with hypovolaemia and hyponatraemia were surveyed retrospectively to observe changes in serum levels of sodium, uric acid (UA) and haematocrit (Hct) following i.v. fluid supplementation of low sodium content (retrospective study). Thirdly, five ACTH-deficient patients with or without overt dehydration were studied with regard to body weight, blood pressure, serum sodium, total proteins, Hct and blood urea nitrogen before and after GC replacement (prospective study). Plasma AVP levels were measured after i.v. fluid supplementation without GC replacement in the patients of the retrospective study, and before and after GC replacement in the patients of the prospective study.


RESULTS
The first patient became more hyponatraemic after i.v. fluid supplementation and recovered ultimately from hyponatraemia after GC replacement. In five patients studied retrospectively, the serum sodium levels fell progressively following i.v. fluid supplementation, concurrent with reduction in UA levels and Hct, which indicated the dilutional nature of the hyponatraemia. In the patients observed prospectively, the accumulation of fluid and sodium was indicated by a rise in body weight, blood pressure and serum sodium levels and a decline in Hct and total proteins after GC replacement. Plasma AVP levels rose similarly in patients with dilutional hyponatraemia and in patients with borderline hyponatraemia before GC replacement.


CONCLUSIONS
Patients with untreated ACTH deficiency may have either of two kinds of hyponatraemia--i.e. borderline hyponatraemia associated with subclinical hypovolaemia, or dilutional hyponatraemia. Similarity of plasma AVP levels in two hyponatraemic states suggests their AVP secretion is regulated by non-osmotic, non-volume mechanisms, possibly released from GC suppression at low plasma osmolality.
Yamamoto
T
T
Kishiwada Tokushukai Hospital, Osaka, Japan.
Fukuyama
J
J
Kabayama
Y
Y
Harada
H
H
D000324:Adrenocorticotropic Hormone / Q000172:deficiency*; D000328:Adult; D000368:Aged; D001127:Arginine Vasopressin / Q000097:blood*; D005260:Female; D005440:Fluid Therapy; D005938:Glucocorticoids / Q000008:administration & dosage; D006400:Hematocrit; D006801:Humans; D007010:Hyponatremia / Q000097:blood* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010953:Plasma Volume; D011446:Prospective Studies; D012189:Retrospective Studies; D014527:Uric Acid / Q000097:blood
D005938:Glucocorticoids; D001127:Arginine Vasopressin; D014527:Uric Acid; D000324:Adrenocorticotropic Hormone